![](/wp-content/uploads/2019/12/dexcom-senseonics-onduo_announcement.png)
$599
Senseonics Launches Non-Adjunctive Claim; Dexcom Data Transmission Issue; Onduo RWE Published
A series of diabetes-related news has been observed including Senseonics’s launch of its Eversense implantable CGM non-adjunctive claim, an issue with Dexcom’s CGM follow app, and new Onduo real-world evidence. Below, FENIX provides highlights and insights from the respective news.